Child development and behaviour Other
Conditions
Interventions
Current intervention as of 01/04/2022:
The home visit intervention was suspended in March 2020. At that time intervention had begun in 6 of 13 health districts in which the study was planned. We modi
Sponsors
The University of the West Indies
Eligibility
Sex/Gender
All
Age
5 Months to 24 Months
Inclusion criteria
Inclusion criteria: 1. The child is between 5-24 months At least one of the following: 1. The child referred to the nutrition clinic for under-nutrition 2. Child whose last recorded height-for-age measurement was below -1SD of the WHO reference standards 3. Families where the child or mother is registered with the conditional cash transfer programme (PATH) 4. Mothers who are currently pregnant with a child under 2 years of age 5. Children who live in low socioeconomic environments 6. Adolescent mothers 16-19 years
Exclusion criteria
Exclusion criteria: 1. Child is in Daycare or has no consistent caregiver 2. The baby has a major disability likely to affect their development 3. Mother is aged under 16 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measure as of 01/04/2022: 1. Child Developmental Quotient (Total Score) is measured using the Griffiths Mental Development Scales- Extended Revised (GMDS-ER) (ARICD, 2006) at the end of the trial. 2. Mother/caregiver stimulation in the home (Total Score) measured using an adaptation of the Family Care Indicators questionnaire administered by telephone interview at the end of the trial. Previous primary outcome measure: 1. Child Developmental Quotient (Total Score) is measured using the Griffiths Mental Development Scales- Extended Revised (GMDS-ER) (ARICD, 2006) at the end of the trial. 2. Mother/caregiver stimulation in the home (Total Score) is measured using the Infant/Toddler HOME questionnaire (Caldwell, 2003) at enrollment and at the end of the trial. | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 01/04/2022: 1. Child development Sub-scales (Hearing and Language, Eye and Hand Coordination and Performance) are measured using the Griffiths Mental Development Scales- Extended Revised (GMDS-ER) (ARICD, 2006) at the end of the trial. 2. Maternal attitudes to child development are measured using the Parenting attitudes questionnaire at enrollment and at the end of the trial. 3. Maternal depressive symptoms are measured using the Center for Epidemiological Studies-Depression Scale (CES-D) (Radloff, 1977) at enrollment and at the end of the trial. 4. Maternal/caregiver stimulation in the home (Sub-scales: Involvement, Organization, Variety, Responsivity, Acceptance and Learning Materials) measured using an adaptation of the Family Care Indicators questionnaire administered by telephone interview at the end of the trial. Previous secondary outcome measures: 1. Child development Sub-scales (Hearing and Language, Eye and Hand Coordination and Performance) are measured using the Griffiths Mental Development Scales- Extended Revised (GMDS-ER) (ARICD, 2006) at the end of the trial. 2. Maternal attitudes to child development are measured using the Parenting attitudes questionnaire at enrollment and at the end of the trial. 3. Maternal depressive symptoms are measured using the Center for Epidemiological Studies-Depression Scale (CES-D) (Radloff, 1977) at enrollment and at the end of the trial. 4. Maternal/caregiver stimulation in the home (Sub-scales: Involvement, Organization, Variety, Responsivity, Acceptance and Learning Materials) is measured using the Infant/Toddler HOME questionnaire (Caldwell, 2003) at enrollment and at the end of the trial. | — |
Countries
Jamaica
Contacts
Public ContactSusan Chang-Lopez
Outcome results
None listed